Metabolic conversion of dietary flavonoids alters their anti-inflammatory and antioxidant properties.

[1]  A. Reunanen,et al.  Flavonoid intake and risk of chronic diseases. , 2002, The American journal of clinical nutrition.

[2]  D. Boschelli,et al.  Inhibition of tumor necrosis factor induced human aortic endothelial cell adhesion molecule gene expression by an alkoxybenzo[b]thiophene-2-carboxamide. , 1995, Biochemical and biophysical research communications.

[3]  G. Williamson,et al.  Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.

[4]  Sandra N. Mohr,et al.  Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  J. McMillan,et al.  Covalent binding of the flavonoid quercetin to human serum albumin. , 2005, Journal of agricultural and food chemistry.

[6]  R. Tyrrell,et al.  Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts. , 2003, Free radical biology & medicine.

[7]  S. Sang,et al.  Bioavailability issues in studying the health effects of plant polyphenolic compounds. , 2008, Molecular nutrition & food research.

[8]  P. Dagnelie,et al.  Deconjugation kinetics of glucuronidated phase II flavonoid metabolites by beta-glucuronidase from neutrophils. , 2010, Drug metabolism and pharmacokinetics.

[9]  R. Tyrrell,et al.  Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. , 2001, The Biochemical journal.

[10]  T. Inakuma,et al.  Protection by quercetin and quercetin 3-O-β-D-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein , 2001, Free radical research.

[11]  Y. Moon,et al.  Quercetin pharmacokinetics in humans , 2008, Biopharmaceutics & drug disposition.

[12]  Ni Ai,et al.  Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. , 2005, Biochemical pharmacology.

[13]  P. Hollman,et al.  Absorption and disposition kinetics of the dietary antioxidant quercetin in man. , 1996, Free radical biology & medicine.

[14]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[15]  H. Sies,et al.  Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. , 2008, Archives of biochemistry and biophysics.

[16]  M. Yoshizumi,et al.  Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. , 2002, Biochemical and biophysical research communications.

[17]  J. Terao,et al.  Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-D-glucuronide, on lipid peroxidation in liposomal membranes. , 2001, Journal of agricultural and food chemistry.

[18]  Chi-Tang Ho,et al.  Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. , 2002, Chemical research in toxicology.

[19]  O. Kucuk,et al.  Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. , 2010, Life sciences.

[20]  C. Fraga,et al.  Epicatechin in human plasma: in vivo determination and effect of chocolate consumption on plasma oxidation status. , 2000, The Journal of nutrition.

[21]  G. Jacobasch,et al.  Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans , 2001, Journal of clinical pharmacology.

[22]  N. Shibata,et al.  Macrophage as a Target of Quercetin Glucuronides in Human Atherosclerotic Arteries , 2008, Journal of Biological Chemistry.

[23]  M. Clifford,et al.  Dietary phenolics: chemistry, bioavailability and effects on health. , 2009, Natural product reports.

[24]  K. Croft.  The Chemistry and Biological Effects of Flavonoids and Phenolic Acids a , 1998, Annals of the New York Academy of Sciences.

[25]  J. Terao,et al.  Effect of quercetin conjugates on vascular permeability and expression of adhesion molecules , 2004, BioFactors.

[26]  H. Neil,et al.  The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies , 2003, European Journal of Clinical Nutrition.

[27]  T. Maniatis,et al.  Transcriptional regulation of endothelial cell adhesion molecules : NF-icB and cytokine-inducible enhancers , 2004 .

[28]  S. Blankenberg,et al.  Adhesion molecules and atherosclerosis. , 2003, Atherosclerosis.

[29]  S. Legrand-Poels,et al.  NF-κB activation by reactive oxygen species: Fifteen years later , 2006 .

[30]  J. Terao,et al.  Attenuation of lipid peroxidation and hyperlipidemia by quercetin glucoside in the aorta of high cholesterol-fed rabbit , 2005, Free radical research.

[31]  C. Pagliuca,et al.  Polyphenol metabolites from colonic microbiota exert anti-inflammatory activity on different inflammation models. , 2009, Molecular nutrition & food research.

[32]  D. Barron,et al.  Human metabolism of dietary flavonoids: Identification of plasma metabolites of quercetin , 2001, Free radical research.

[33]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[34]  C. Falany,et al.  Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. , 1998, The American journal of clinical nutrition.

[35]  R. Lamuela-Raventós,et al.  Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells , 2009, British Journal of Nutrition.

[36]  E. Feskens,et al.  Dietary flavonoids and cancer risk in the Zutphen Elderly Study. , 1994, Nutrition and cancer.

[37]  E. Feskens,et al.  Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study , 1993, The Lancet.

[38]  Andrea Bonanome,et al.  Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. , 2002, The American journal of medicine.

[39]  S. Legrand-Poels,et al.  NF-kappaB activation by reactive oxygen species: fifteen years later. , 2006, Biochemical pharmacology.

[40]  Y. Lee,et al.  Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. , 2009, Biological & pharmaceutical bulletin.

[41]  J J Strain,et al.  The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.

[42]  Moira A. Taylor,et al.  Comparative effects of quercetin and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells. , 2008, Atherosclerosis.

[43]  Ilja C W Arts,et al.  Polyphenols and disease risk in epidemiologic studies. , 2005, The American journal of clinical nutrition.

[44]  A. García-Lafuente,et al.  Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease , 2009, Inflammation Research.

[45]  B. Frei,et al.  Dietary flavonoids attenuate tumor necrosis factor alpha-induced adhesion molecule expression in human aortic endothelial cells. Structure-function relationships and activity after first pass metabolism. , 2006, The Journal of biological chemistry.

[46]  A. Palmer,et al.  Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery , 2005, NeuroRX.

[47]  H N Graham,et al.  Green tea composition, consumption, and polyphenol chemistry. , 1992, Preventive medicine.

[48]  J H Weisburger,et al.  Tea and health: a historical perspective. , 1997, Cancer letters.

[49]  M. Natsume,et al.  Inhibitory Effects of Conjugated Epicatechin Metabolites on Peroxynitrite-mediated Nitrotyrosine Formation , 2007, Journal of clinical biochemistry and nutrition.

[50]  T. Kinoshita,et al.  Effect of a conjugated quercetin metabolite, quercetin 3-glucuronide, on lipid hydroperoxide-dependent formation of reactive oxygen species in differentiated PC-12 cells , 2006, Free radical research.

[51]  J. Terao,et al.  (-)-Epicatechin gallate accumulates in foamy macrophages in human atherosclerotic aorta: implication in the anti-atherosclerotic actions of tea catechins. , 2008, Biochemical and biophysical research communications.

[52]  Hyun Pyo Kim,et al.  Anti-inflammatory plant flavonoids and cellular action mechanisms. , 2004, Journal of pharmacological sciences.

[53]  L. Moreno,et al.  Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. , 2009, Atherosclerosis.

[54]  M. Khan,et al.  Food as medicine: potential therapeutic tendencies of plant derived polyphenolic compounds. , 2008, Asian Pacific journal of cancer prevention : APJCP.